tiprankstipranks
Trending News
More News >

Kyocera Announces Strategic Split of Medical Business

Story Highlights
Kyocera Announces Strategic Split of Medical Business

Confident Investing Starts Here:

Kyocera ( (JP:6971) ) has provided an announcement.

Kyocera Corporation announced a strategic move to split its medical business into a newly formed subsidiary, Kyocera Medical Corporation, through an absorption-type company split effective October 1, 2025. This restructuring aims to enhance the company’s ability to meet the evolving demands of the medical device industry, improve responsiveness to regulatory changes, and accelerate business growth, ultimately contributing to the global medical market’s development.

The most recent analyst rating on (JP:6971) stock is a Buy with a Yen2000.00 price target. To see the full list of analyst forecasts on Kyocera stock, see the JP:6971 Stock Forecast page.

More about Kyocera

Kyocera Corporation operates in the medical device industry, focusing on the development, manufacturing, and sale of artificial joints and dental implants. The company aims to address the increasing international requirements for safety and quality in the medical device sector.

Average Trading Volume: 4,748,106

Technical Sentiment Signal: Strong Buy

Current Market Cap: Yen2415.1B

See more insights into 6971 stock on TipRanks’ Stock Analysis page.

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.

Report an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App